Study examines role of biomarkers to evaluate kidney injury in cancer patients
Ground-breaking evidence reveals scalp cooling physically protects hair follicles
3 February 2021Experimental HIV vaccine primed immune system as first stage in production of broadly neutralizing antibodies
3 February 2021Study examines role of biomarkers to evaluate kidney injury in cancer patients
A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells.
